LOVENOX®-: Treatment for Deep Vein Thrombosis (DVT) Blood Clots
Links shared publicly online about this topic.
- 1,548total visits
LOVENOX®-: Treatment for Deep Vein Thrombosis (DVT) Blood Clots
View full resource at lovenox.com
Tags: Blood Clot, Anti-Clotting Medication, Anticoagulant, Lovenox, Sanofi-Aventis, Pulmonology, #HCSM, #HCMKTG
Most Recently Shared on December 7, 2009 at 4:12 pm By:
For @RosettaHC & others keeping score at home re Sanofi-Aventis Lovenox #sidewiki http://j.mp/6TtjFR Legal:1, Mktg:0 #hcsm #hcmktg #pbecomm
Comments of using Lovenox (study 6064699) - eHealthMe.com
ehealthme.com — “Was on 40mg lovenox for 5 days after surgery, and menstrual had started 4 days prior to taking lovenox and 15 days later I am still menstruating.” View full resource at ehealthme.com
Most Recently Shared on March 16, 2012 at 12:29 am By:
Was on 40mg lovenox for 5 days after surgery, and menstrual had started 4 days prior to taking lovenox and 15 http://t.co/VqnN7b0O
Lovenox For 1 1/2 Yrs (Newest posts first) - The People's Medicine Community
prescriptiondrug-info.com — “I have been taking Lovenox for 1 1 2 years for a DVT ankle to groin and multiple clots in my lungs all four quadrants No one can figure out WHY I grew the super clot it did not reabsorb and is still there I had a Tulip filter put in before surgery remove ovary because suspected cancer pathology was (Newest posts first)” View full resource at prescriptiondrug-info.com
Most Recently Shared on March 14, 2012 at 5:35 am By:
" I have been taking Lovenox for 1 1/2 years for a DVT (ankle to groin) and multiple clots in my lungs (all fo http://t.co/6f1Qs8Xh
FDA Approves Generic Lovenox - WSJ.com
online.wsj.com — “A California biotechnology company won FDA approval to sell a generic version of the blockbuster blood thinner Lovenox, following a years-long battle that was unusually bitter.” View full resource at online.wsj.com
Most Recently Shared on September 20, 2011 at 5:22 am By:
New Generic Lovenox Receives FDA Approval: A California biotechnology company won FDA… http://t.co/od2YFrt7
FDA Approves Watson Pharmaceuticals Generic Lovenox (Enoxaparin) - Forbes
forbes.com — “The FDA has granted approval to Amphastar's generic version of Lovenox (enoxaparin sodium), Watson Pharmaceuticals has announced. The low molecular weight heparin will be sold by Watson under an arrangement with Amphastar. In July 2010 the FDA approved the first generic version of enoxaparin, manufactured by Sandoz and marketed in the US [...]” View full resource at forbes.com
Most Recently Shared on September 19, 2011 at 11:29 pm By:
FDA Approves Watson Pharmaceuticals Generic Lovenox (Enoxaparin): The FDA has granted approval to Ampha... http://t.co/EArfuZXO #drug
lovenox - Lap Band Talk Forums
lapbandtalk.com — “I have an autoimmune disease called Antiphospholipid Syndrome, also known as APS, that causes my blood to clot abnormally. I've been taking Love...” View full resource at lapbandtalk.com
Most Recently Shared on June 6, 2011 at 5:09 am By:
theheart.org: trusted cardiology news and opinions
theheart.org — “The latest developments in cardiology and cardiovascular research, including heartwire news and commentary by some of the world's top cardiologists. Sign up for free.” View full resource at theheart.org
Most Recently Shared on May 27, 2011 at 6:05 pm By:
Senate finance committee implies Sanofi paid petitioners to help delay generic Lovenox: A new report from the Se... http://bit.ly/ki3tlr
Sanofi-Aventis, Medtronic under scrutiny in press reports
news-medical.net — “ProPublica details alleged activities by Sanofi-Aventis to influence regulators regarding its brand-name blood thinner, Lovenox, while other news outlets report on Medtronic's activities related to a biological agent used in back surgery.” View full resource at news-medical.net
Most Recently Shared on May 27, 2011 at 10:38 am By:
Sanofi-Aventis, Medtronic under scrutiny in press reports: ProPublica details alleged activities by Sanofi-Avent... http://bit.ly/mg4cPW
Sanofi-Aventis, Medtronic Under Scrutiny In Press Reports - Kaiser Health News
kaiserhealthnews.org — “ProPublica details alleged activities by Sanofi-Aventis to influence regulators regarding its brand-name blood thinner, Lovenox, while other news outlets report on Medtronic's activities related to a biological agent used in back surgery.” View full resource at kaiserhealthnews.org
Most Recently Shared on May 26, 2011 at 2:20 pm By:
Sanofi-Aventis, Medtronic Under Scrutiny In Press Reports http://bit.ly/khA7HE
Sanofi Pays Doctors to Dis Generic Version of Lovenox - Pharma Marketing Network Forums
forums.pharma-mkting.com — “Sanofi Pays Doctors to Dis Generic Version of Lovenox Industry News” View full resource at forums.pharma-mkting.com
Most Recently Shared on May 25, 2011 at 2:57 pm By:
Find Senate letter & report re Sanofi "strategic use" of physicians to dis generic version of Levenox here: http://ow.ly/52Ilr
Senate Panel Hits Sanofi Payments - WSJ.com
online.wsj.com — “Sanofi contributed to two medical groups and a researcher that encouraged regulators to delay approval of a drug that would undercut its Lovenox, according to a Senate panel report.” View full resource at online.wsj.com
Most Recently Shared on May 25, 2011 at 10:30 am By:
http://ow.ly/52tUa US Senate criticizes Sanofi for $5 million to med groups that encouraged regulators to slow approval of drug
Lovenox and pumps - TuDiabetes
tudiabetes.org — “I most likely be on Lovenox (injections) which is a blood thinner like Heparin not Coumadin. I am one and million that is allergic to Coumadin. I am planning o--” View full resource at tudiabetes.org
Most Recently Shared on April 7, 2011 at 1:15 am By:
Insulin pumps: Lovenox and pumps: I most likely be on Lovenox (injections) which is a blood thinner like Hepari... http://tud4.us/f44haG
Medical News: ACC: Mixed Results for Factor Xa Drug in Medical Ward - in Meeting Coverage, ACC from MedPage Today
medpagetoday.com — “NEW ORLEANS -- An extended course of the novel anticoagulant rivaroxaban (Xarelto) may prevent venous thromboembolism better than a standard course of enoxaparin (Lovenox) in acutely-ill medical patie” View full resource at medpagetoday.com
Most Recently Shared on April 6, 2011 at 5:29 pm By:
ACC: Mixed Results for Factor Xa Drug in Medical Ward (CME/CE): NEW ORLEANS (MedPage Today… http://goo.gl/fb/1y978
ACC: Mixed Results for Factor Xa Drug in Medical Ward (CME/CE) - QualityPoint Technologies
qualitypointtech.net — “NEW ORLEANS (MedPage Today) -- An extended course of the novel anticoagulant rivaroxaban (Xarelto) may prevent venous thromboembolism better than a standard course of enoxaparin (Lovenox) in acutely-ill medical patients, but at the cost of more bleeding, researchers found.” View full resource at qualitypointtech.net
Most Recently Shared on April 6, 2011 at 4:35 pm By:
ACC: Mixed Results for Factor Xa Drug in Medical Ward (CME/CE): NEW ORLEANS (MedPage Today) -- An extended course ... http://bit.ly/enJgQe
Medical News: ACC: Mixed Results for Factor Xa Drug in Medical Ward - in Meeting Coverage, ACC from MedPage Today
medpagetoday.com — “NEW ORLEANS -- An extended course of the novel anticoagulant rivaroxaban (Xarelto) may prevent venous thromboembolism better than a standard course of enoxaparin (Lovenox) in acutely-ill medical patie” View full resource at medpagetoday.com
Most Recently Shared on April 6, 2011 at 4:20 pm By:
ACC: Mixed Results for Factor Xa Drug in Medical Ward (CME/CE) http://bit.ly/gpxYml
DAVOS-UPDATE 1-Sanofi CEO sees progress in Genzyme talks | Reuters
reuters.com — “* No meetings planned but CEOs may run into other in Davos * Sanofi CEO says CVR could offer significant value * Sanofi already braced for generic Lovenox from Teva (Adds further quotes, detail” View full resource at reuters.com
Most Recently Shared on January 26, 2011 at 11:24 am By:
Sanofi's Viehbacher tells Reuters there's progress in Genzyme talks - may run into Termeer in #Davos #WEF $GENZ http://reut.rs/e9GpvL
Advertisement

